Length and Somatic Mosaicism of CAG and GGN Repeats in the Androgen Receptor Gene and the Risk of Prostate Cancer in Men with Benign Prostatic Hyperplasia

Overview

Journal Ann Saudi Med

Specialty General Medicine

Date 2004 Aug 18

PMID 15310009

Citations 2

Authors

Mohammed T Tayeb

Caroline Clark

Graeme I Murray

Linda Sharp

Neva E Haites

Howard L McLeod

Affiliations

Soon will be listed here.

Abstract

Background: The most common malignancy in men worldwide is cancer of the prostate and determinants of prostate cancer (PRCa) risk remain largely unidentified. Many candidate genes may be involved in PRCa, such as those that are central to cellular growth and differentiation in the prostate gland. We analysed the polymorphic CAG and GGN repeats sequence in exon 1 of the AR gene to determine if the number of repeats might be an indicator of PRCa risk in patients with BPH.

Methods: The study evaluated 28 patients who presented with PRCa at least 6 years after the diagnosis of BPH and 56 matched patients with BPH who did not progress to PRCa over a comparable period.

Results: This study showed no evidence for association between the size of AR CAG and GGN repeats and the risk of the development of PRCa in patients with BPH. However, BPH patients with AR CAG instability had a 12-fold increased risk in development of PRCa.

Conclusions: While independent confirmation is required in further studies, these results provide a potential tool to assist prediction strategies for this important disease.

Citing Articles

(CAG) Microsatellite and c.444T>G (p.Asp148Glu) Polymorphisms as Independent Prognostic Biomarkers in Prostate Cancer: Insights from an Argentinian Cohort.

Pascual G, Sabater A, Bizzotto J, Seniuk R, Sanchis P, Ledesma-Bazan S Cancers (Basel). 2024; 16(22).

PMID: 39594771 PMC: 11592882. DOI: 10.3390/cancers16223815.

Germline Mutations and Polymorphisms of Androgen Receptor in Prostate Cancer Patients: Frequency and Results of in Silico Analysis.

Sribudiani Y, Marwan D, Aulanniam A, Widodo M, Purnomo B, Panigoro R Asian Pac J Cancer Prev. 2018; 19(8):2241-2245.

PMID: 30139231 PMC: 6171394. DOI: 10.22034/APJCP.2018.19.8.2241.

References

Mangiarini L, Sathasivam K, Mahal A, Mott R, Seller M, Bates G . Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nat Genet. 1997; 15(2):197-200. DOI: 10.1038/ng0297-197. View

Tayeb M, Clark C, Haites N, Sharp L, Murray G, McLeod H . Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia. Saudi Med J. 2004; 25(4):447-51. View

Giovannucci E, Stampfer M, Chan A, Krithivas K, Gann P, Hennekens C . CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians. Prostate. 1999; 39(2):130-4. DOI: 10.1002/(sici)1097-0045(19990501)39:2<130::aid-pros8>3.0.co;2-#. View

Chamberlain N, Driver E, Miesfeld R . The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994; 22(15):3181-6. PMC: 310294. DOI: 10.1093/nar/22.15.3181. View

Wohr G, Haussler J, Berthon P, Drelon E, Mangin P, Fournier G . (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet. 1999; 7(3):357-62. DOI: 10.1038/sj.ejhg.5200298. View

Lange E, Chen H, Brierley K, Livermore H, Wojno K, Langefeld C . The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer. Cancer Epidemiol Biomarkers Prev. 2000; 9(4):439-42. View

Mitsumori K, Terai A, Oka H, Segawa T, Ogura K, Yoshida O . Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth. Prostate. 1999; 41(4):253-7. DOI: 10.1002/(sici)1097-0045(19991201)41:4<253::aid-pros5>3.0.co;2-9. View

FRANKS L, Wilson P . "Spontaneous" neoplastic transformation in vitro: the ultrastructure of the tissue culture cell. Eur J Cancer (1965). 1970; 6(6):517-23. DOI: 10.1016/0014-2964(70)90072-1. View

Kantoff P, Giovannucci E, Brown M . The androgen receptor CAG repeat polymorphism and its relationship to prostate cancer. Biochim Biophys Acta. 1999; 1378(3):C1-5. DOI: 10.1016/s0304-419x(98)00023-7. View

10.

Bostwick D, COONER W, Denis L, Jones G, Scardino P, Murphy G . The association of benign prostatic hyperplasia and cancer of the prostate. Cancer. 1992; 70(1 Suppl):291-301. DOI: 10.1002/1097-0142(19920701)70:1+<291::aid-cncr2820701317>3.0.co;2-4. View

11.

Tayeb M, Clark C, Haites N, Sharp L, Murray G, McLeod H . CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia. Br J Cancer. 2003; 88(6):928-32. PMC: 2377095. DOI: 10.1038/sj.bjc.6600825. View

12.

Bratt O, Borg A, Kristoffersson U, Lundgren R, Zhang Q, Olsson H . CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk. Br J Cancer. 1999; 81(4):672-6. PMC: 2362888. DOI: 10.1038/sj.bjc.6690746. View

13.

Stanford J, JUST J, Gibbs M, Wicklund K, Neal C, Blumenstein B . Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res. 1997; 57(6):1194-8. View

14.

Terrell R, Wille A, Cheville J, Nystuen A, Cohen M, Sheffield V . Microsatellite instability in adenocarcinoma of the prostate. Am J Pathol. 1995; 147(3):799-805. PMC: 1870975. View

15.

Choong C, Kemppainen J, Zhou Z, Wilson E . Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol. 1996; 10(12):1527-35. DOI: 10.1210/mend.10.12.8961263. View

16.

SCHUMAN L, Mandel J, Blackard C, Bauer H, Scarlett J, McHugh R . Epidemiologic study of prostatic cancer: preliminary report. Cancer Treat Rep. 1977; 61(2):181-6. View

17.

Hakimi J, Schoenberg M, Rondinelli R, Piantadosi S, Barrack E . Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res. 1998; 3(9):1599-608. View

18.

Tanaka F, Reeves M, Ito Y, Matsumoto M, Li M, Miwa S . Tissue-specific somatic mosaicism in spinal and bulbar muscular atrophy is dependent on CAG-repeat length and androgen receptor--gene expression level. Am J Hum Genet. 1999; 65(4):966-73. PMC: 1288267. DOI: 10.1086/302578. View

19.

Lichtenstein P, Holm N, Verkasalo P, Iliadou A, Kaprio J, Koskenvuo M . Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000; 343(2):78-85. DOI: 10.1056/NEJM200007133430201. View

20.

FRALEY E, Ecker S, VINCENT M . Spontaneous in vitro neoplastic transformation of adult human prostatic epithelium. Science. 1970; 170(3957):540-2. DOI: 10.1126/science.170.3957.540. View